Downregulation of Cdc6 inhibits tumorigenesis of osteosarcoma in vivo and in vitro

This publication has 29 references indexed in Scilit:

• WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck
  Oncotarget, 2016
• Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells
  Oncotarget, 2016
• High expression of CDC6 is associated with accelerated cell proliferation and poor prognosis of epithelial ovarian cancer
  Pathology - Research and Practice, 2016
• Expression of CDc6 after acute spinal cord injury in adult rats
  Neuropeptides, 2016
• 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway
  Oncotarget, 2016
• Cdc6: A multi-functional molecular switch with critical role in carcinogenesis
  Transcription, 2012
• Replication licensing promotes cyclin D1 expression and G₁progression in untransformed human cells
  Cell Cycle, 2009
• Growth inhibition of hepatocellular carcinoma cells in vitro and in vivo by the 8-methoxy analog of WMC79
  Cancer Chemotherapy and Pharmacology, 2008
• The functional role of Cdc6 in S–G2/M in mammalian cells
  EMBO Reports, 2006
• Human replication protein Cdc6 prevents mitosis through a checkpoint mechanism that implicates Chk1
  The EMBO Journal, 2003